A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma.
One third of patients with stage T1 urothelial carcinoma (UC) progress to muscle-invasive disease requiring radical surgery. Thus, reliable tools are needed for risk stratification of stage T1 UC.